Resources Library by ANA

Adapting consumer choice modelling for the pharmaceutical industry

The authors discuss the development of a flexible Attitude -to - Behaviour model, originally developed to explore viable product developments in the communications market. The model has been applied to pharmaceutical marketing research, using patient...

Catalogue: EphMRA/ESOMAR Seminar 1991: 1993 And Beyond

Authors: Eric Willson, Kevin Mahoney

Company: KANTAR TNS Malaysia

June 15, 1991

The relevance of the Canadian and US market experience public policy considerations

There is a direct relationship between the degree to which markets differ and the need for market research. Predicting how the EC member states will differ therefore provides insight into the future of market research. Observing what has happened...

Catalogue: EphMRA/ESOMAR Seminar 1991: 1993 And Beyond

Author: Tom Brogan

June 15, 1991

Pharmaceutical pricing

With the increasing demands on health care expenditure due to a rise in the proportion of people aged 65 or more. Governments are and will continue to explore ways of reducing costs. It is likely that their focus will be towards the drugs bill rather...

Catalogue: EphMRA/ESOMAR Seminar 1991: 1993 And Beyond

Authors: Diana Grose, Alan J. Bowditch

June 15, 1991

A market model used to develop the positioning platform for a new antihypertensive

The paper is divided into two parts. The first part explains the market model used to represent the antihypertensive market in Italy. The model takes into account the nature of the prescribing situation and its anomaly with respect to many consumer...

Catalogue: EphMRA/ESOMAR Seminar 1991: 1993 And Beyond

Author: Nigel J. Burrows

June 15, 1991

Economic evaluation in health care

The objective of this contribution is to briefly outline the broad category of cost- benefit analysis and its potential to provide a meaningful instrument in marketing concepts for pharmaceuticals. First, the incentives for the interest in...

Catalogue: EphMRA/ESOMAR Seminar 1991: 1993 And Beyond

Author: Angela Kempel

June 15, 1991

Standardization of health measurement for different indications

A comparison of treatment regimes in the health service shows that different demands are made of the measuring instruments depending on the indication and national pecuharities. In searching for the most universally applicable procedure possible, we...

Catalogue: EphMRA/ESOMAR Seminar 1991: 1993 And Beyond

Author: Peter Becker

June 15, 1991

The use of prescription data for sales force management and market research

This paper is divided into five sections; the first describes the data, which are collected from retail pharmacies and provide comprehensive information on the prescription drug sales transaction. Prescription characteristics, e.g. amount of drug...

Catalogue: EphMRA/ESOMAR Seminar 1991: 1993 And Beyond

Author: Patrick Miller

June 15, 1991

How should we communicate with the over 50's on health and prevention?

It was not so long ago that health was essentially understood as the absence of illness - a precious, heaven-sent gift outside of individual control. This idea - which contains an undeniable element of truth - still predominates in certain parts of...

Catalogue: Seminar 1991: The Over 50's In The 90's

Author: Margret Ziegler

June 15, 1991

(Data + data) × intelligence= Information

This paper will serve to re-emphasise several of the points made by the previous speaker, as well as revisiting other aspects of data interpretation in the pharmaceutical industry. It examines several of the more important areas where data...

Catalogue: EphMRA/ESOMAR Seminar 1991: 1993 And Beyond

Author: Charles Galsworthy

June 15, 1991